Relation Therapeutics

The company's platform leverages ActiveGraph ML, a machine learning technology that has been successfully used by tech companies to solve problems in computer vision and product recommendations. However, RelationRx is the first to use this technology in drug discovery at such a large scale. With ActiveGraph ML, the company can understand the vast number of combinatorial functional relationships between genes, proteins, and drugs.

RelationRx is also pioneering a "Lab-in-the-Loop" approach that integrates active learning at every step of drug discovery, from predicting cell states to validating new targets. The company uses real cells from proprietary biobanks to generate genomic data, providing direct insights into critical biological relationships. This data is then fed into the machine learning systems, which request new experiments to improve their predictive ability.

The company's business model revolves around using its platform to discover new therapeutics. It generates revenue by licensing its discoveries to pharmaceutical companies for further development and commercialization.

In summary, RelationRx is a biotech startup that uses machine learning to revolutionize drug discovery. Its innovative approach could potentially lead to the discovery of treatments for diseases that are currently untreatable.